Keywords
COVID-19
Data Correlation
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the main factors related to post-COVID Telogen Effluvium. Methods: In this integrative review, articles were selected from the Science Direct, Portal Capes and U.S. National Library of Medicine (PubMed) databases. The search descriptors were: “Telogen Effluvium”, “COVID-19” and “Data Collection”, articulated with the Boolean operator “AND”. With the adoption of articles published between the years 2020 and 2022, in English, online resource and open access and exclusion of duplicates in the chosen databases and those that did not provide answers to the base question for the research, 17 articles remained. Results: COVID-19 influences hair loss after infection from some factors, such as: immune factors, which include the elevation of pro-inflammatory cytokines, microthrombotic reaction in hair follicles, drug reaction and deposition of immune complexes. In addition to psychic factors such as stress and anxiety. Final considerations: Therefore, coronavirus infection is directly related to hair loss, regardless of the factor involved, and it is important to familiarize and prepare professionals on the subject.
References
ASGHAR F, et al. Telogen Effluvium: A Review of the Literature. Cureus, 2020; 12(5).
BABAEI K, et al. Characteristics of telogen effluvium in COVID-19 in western Iran. Anais Brasileiros de Dermatologia, 2021; 96(6).
CLINE A, et al. A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19. J Am Acad Dermatol, 2021a; 84(3) :773-775.
CLINE A, et al. Race, ethnicity, and comorbidities are critical factors in the diagnosis of telogen effluvium during the COVID-19 pandemic. Journal of the American Academy of Dermatology, 2021b; 85(1): 209-211.
FERNÁNDEZ-LÁZARO D, GARROSA M. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review. Viruses, 2021; 13(10).
GARCES SBB. Classificação e tipos de pesquisas. Universidade de Cruz Alta–Unicruz, 2010.
GENTILE P. Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies. International Journal of Molecular Sciences, 2022; 23(6).
HAN J, et al. Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends. JMIR Dermatology, 2022; 5(2).
LARIJANI MS, et al. Characterization of long COVID-19 manifestations and its associated factors: A prospective cohort study from Iran. Microbial Pathogenesis, 2022; 169.
LIMA PCQMC, BRANDÃO BJF. Eflúvio Telógeno Agudo e Alopecia Areata Associada a COVID-19. BWS Journal, 2022; 5.
LV S, et al. A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection. Clinical, Cosmetic and Investigational Dermatology, 2021; 14: 385-87.
MONARI P, et al. Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication. Journal of Clinical Medicine, 2022; 11(5): 1234.
MÜLLER-RAMOS P, et al. Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. International journal of dermatology, 2022; 61(5): 162–164.
NALBANDIAN A, et al. Post-acute COVID-19 syndrome. Nature Medicine, 2021; 27: 601–615.
NATÁRIO JAA, et al. A queda capilar pode ser considerada uma das consequências da COVID-19? Research, Society and Development, 2022; 11(1).
OLIVEIRA IM, BRANDÃO BJF. Tratamento do Eflúvio Telógeno Pós-Covid. BWS Journal, 2021; 4:1-8.
PEGHIN M, et al. Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients. Clinical Microbiology and Infection, 2022; 28(8): 1140-1148.
PROAL AD, VANELZAKKER MB. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Frontiers in microbiology, 2021; 12.
QAMAR MA, et al. Residual symptoms and the quality of life in individuals recovered from COVID-19 infection: A survey from Pakistan. Annals of Medicine and Surgery, 2022; 75.
RECALCATI S, et al. COVID-19: The experience from Italy. Clinics in Dermatology, 2021; 39(1):12-22.
RODA A., SOARES RO. Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2. Revista Da Sociedade Portuguesa De Dermatologia E Venereologia, 2021; 79(1): 21-25.
SAKI N, et al. Intermittent Chronic Telogen Effluvium with an Unusual Dermoscopic Finding following COVID‐19. Clinical Case Reports, 2022; 10(8).
SEQUE CA. et al. Skin manifestations associated with COVID-19. Anais Brasileiros de Dermatologia, 2022; 97(1): 75-88.
SEYFI S, et al. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. Journal of medicine and life, 2022; 15(5): 631-634.
SOUZA MT, et al. Revisão integrativa: o que é e como fazer. Einstein, 2010; 8(1): 102-6.
STARACE M, et al. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management. JAAD International, 2021; 5: 11–18.
TURKMEN D, et al. Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire. Dermatologic therapy, 2020; 33(6).